MORE THAN 100 YEARS OF RESEARCH EXCELLENCE. Follow us @UofTB.

Research

Exciting opportunities in 7 major research areas.

People

An international community of faculty and trainees.

Technology

Innovative research platforms.

2019 Biochemistry Retreat

September 4-6th, Geneva Park

Prospective Graduate Students

Applications are now open!

Graduate

A challenging research career is waiting for you.

Undergraduate

Learn from top researchers.

Career Development

An internationally recognized career support program.

Cette Semaine

Seminars, Conferences,
& Other Research Events

Learn Online

Biochemistry
with a Medical Perspective

Accredited Course!

News

  • Departmental News

    Message from the Chair, Justin Nodwell. Hello all, I hope that your returns (partial or otherwise) to lab work have gone as smoothly as possible. None of the ‘new normal’ is perfect and there are…
  • Lewis Kay Elected to the U.S. National Academy of Sciences

    Our esteemed colleague Lewis Kay has been elected to the National Academy of Sciences for his remarkable work on multidimensional NMR. http://www.nasonline.org/news-and-multimedia/news/2020-nas-election.html This is an enormous accomplishment and a rarity for scientists outside the United…
  • Alex Palazzo wins award for excellence in graduate teaching

    Alex Palazzo was awarded a 2019-2020 Faculty of Medicine Graduate Teaching Award for Mid-Career Excellence in Graduate Teaching and Mentorship. Professor Palazzo was one of two recipients honoured with the faculty teaching award in this…
  • How bacterial invaders are sensed in the gut

    A new paper in the latest issue of Science describes how the bacterial-sensing proteins, NOD1/2, are recruited to the membranes of our gut cells for them to function to initiate a proper immune response. This…
  • Angus McQuibban awarded major funding for anti-neurodegenerative diseases drug discovery by AI

    Professor G. Angus McQuibban has just been awarded a $2.3-million Genome Canada grant. The GAPP grant in a partnership with Cyclica and Rosetta Therapeutics (founded by Professors Angus McQuibban and Peter Lewis) will support drug…